4928 Stock Overview
Develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Noevir Holdings Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥4,760.00 |
| 52 Week High | JP¥5,890.00 |
| 52 Week Low | JP¥4,740.00 |
| Beta | -0.058 |
| 1 Month Change | -4.13% |
| 3 Month Change | -11.52% |
| 1 Year Change | -7.03% |
| 3 Year Change | -13.14% |
| 5 Year Change | -18.63% |
| Change since IPO | 28.65% |
Recent News & Updates
Recent updates
Noevir Holdings' (TSE:4928) Dividend Will Be ¥220.00
Sep 10
Noevir Holdings (TSE:4928) Has Announced A Dividend Of ¥220.00
Aug 22Noevir Holdings (TSE:4928) Has Affirmed Its Dividend Of ¥220.00
Jul 22Noevir Holdings (TSE:4928) Is Due To Pay A Dividend Of ¥220.00
Jun 24Noevir Holdings (TSE:4928) Is Paying Out A Dividend Of ¥220.00
Jun 10Noevir Holdings (TSE:4928) Has Affirmed Its Dividend Of ¥220.00
May 13Shareholder Returns
| 4928 | JP Personal Products | JP Market | |
|---|---|---|---|
| 7D | -1.8% | -0.8% | -0.02% |
| 1Y | -7.0% | -9.7% | 14.6% |
Return vs Industry: 4928 exceeded the JP Personal Products industry which returned -9.7% over the past year.
Return vs Market: 4928 underperformed the JP Market which returned 14.6% over the past year.
Price Volatility
| 4928 volatility | |
|---|---|
| 4928 Average Weekly Movement | 1.7% |
| Personal Products Industry Average Movement | 3.7% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 4928 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4928's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1964 | 1,368 | Takashi Okura | www.noevirholdings.co.jp |
Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. The company’s Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; excel make up line products and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs. Its Pharmaceutical & Health Food segment produces and sells Nanten Nodo Ame cough drops; functional drinks, such as the Min Min Da Ha; and over-the-counter pharmaceuticals comprising cold remedies, eye drops, and digestive aids, as well as nutritional supplements, and other products.
Noevir Holdings Co., Ltd. Fundamentals Summary
| 4928 fundamental statistics | |
|---|---|
| Market cap | JP¥162.58b |
| Earnings (TTM) | JP¥7.97b |
| Revenue (TTM) | JP¥63.82b |
20.4x
P/E Ratio2.5x
P/S RatioIs 4928 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4928 income statement (TTM) | |
|---|---|
| Revenue | JP¥63.82b |
| Cost of Revenue | JP¥20.67b |
| Gross Profit | JP¥43.16b |
| Other Expenses | JP¥35.19b |
| Earnings | JP¥7.97b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 05, 2025
| Earnings per share (EPS) | 233.34 |
| Gross Margin | 67.62% |
| Net Profit Margin | 12.49% |
| Debt/Equity Ratio | 0% |
How did 4928 perform over the long term?
See historical performance and comparisonDividends
4.7%
Current Dividend Yield96%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 00:08 |
| End of Day Share Price | 2024/12/25 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Noevir Holdings Co., Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Company Forecast |
| Katsuro Hirozumi | Daiwa Securities Co. Ltd. |
| Taichi Yasumoto | Marusan Securities Co. Ltd. |